AURA

Conviction 60HealthcareScan · Fri, Jun 26, 2026

Bullish harami

AURA$6.98+1.68%

ResistanceSupportVol 14Insider sell

Vol MA14 664.63K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Aura Biosciences, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.aurabiosciences.com ↗

Price6.98

Change+1.68%

Gap+0.95%

Rel volume2.08×

Avg volume582.95K

Avg $ vol3.86M

SMA 206.68

SMA 507.23

SMA 2006.26

Price vs 50-3.55%

Price vs 200+11.37%

MA stackmixed

50/200 cross—

Supertrenddown · 7.35

RSI (14)52

MACD hist0.09

MACD crossbull · 4d

Stoch %K / %D72 / 72

ADX (14)18

+DI / −DI18 / 17

RSI divergence—

MACD divergence—

ATR %+5.84%

ADR %5.72%

52w high8.90

52w low4.97

From 52w high-21.63%

Above 52w low+40.34%

New 52w highNo

SqueezeOff

Bollinger width21.78%

%B0.70

Donchian pos59.81%

Donchian high7.61

Donchian low6.03

AVWAP (52w high)7.58

vs AVWAP high-8.02%

AVWAP (52w low)7.08

vs AVWAP low-1.49%

OBV trendUp

Chaikin MF (20)-0.24

Today vs 20d2.08×

Avg vol (14d)664.63K

Avg vol (20d)582.95K

Avg $ vol (20d)3.86M

Market cap—

RS 3m (vs SPY)-5.93%

RS 6m (vs SPY)+6.73%

RS line new highNo

Trend template6/8

Technical rank57.8

1 week+10.02%

1 month-8.94%

3 months+8.31%

6 months+15.48%

1 year+6.16%

YTD+31.60%

P/E-6.67

P/B6.61

P/S—

P/FCF-8.32

EPS-1.76

Div yield—

ROE-99.02%

ROA-77.13%

Debt/Eq—

Current7.09

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-22.17%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value623.92M

Revenue—

Net income-33.69M

Gross profit—

Free cash flow-85.19M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out103.39M

Employees113

ListedFri, Oct 29, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction60 / 100

Pattern quality—

Tech rank57.8 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AURA

All disclosures →

No recent disclosed trades by Congress in AURA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AURA · 3 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Gibney Anthony S See Remarks · Common Stock · 2026-06-16	Sell	12.82K	$82K	2026-06-16	2026-06-16
Holles Natalie C. See Remarks · Stock Option (Right to Buy) · 2026-05-19	Grant	2.17M	$0	2026-05-19	2026-05-19
Holles Natalie C. See Remarks · Common Stock · 2026-05-19	Grant	553.84K	$0	2026-05-19	2026-05-19
Holles Natalie C. See Remarks · Common Stock · 2026-05-19	Grant	600.12K	$0	2026-05-19	2026-05-19
GOEL DAVID E. 10% owner · Common Stock, par value $0.00001 per share (Common Stock) · 2026-05-07	Sell	6.92M	$39M	2026-05-07	2026-05-11
Matrix Capital Management Company, LP 10% owner · Common Stock, par value $0.00001 per share (Common Stock) · 2026-05-07	Sell	6.92M	$39M	2026-05-07	2026-05-11
Kilroy Conor See Remarks · Common Stock · 2026-04-16	Sell	11.74K	$82K	2026-04-16	2026-04-16

SEC filings

EDGAR filings in AURA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.